Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 13671599112 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Urea, N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(3-fluoro-4-hydroxyphenyl)- | C14H9ClF4N2O2 | 2243399-56-4 | Details |
1-(4-cyano-3-(trifluoroMethyl)phenyl)-3-(3-cyano-4-(trifluoroMethyl)phenyl)thiourea | C17H8F6N4S | 1415564-70-3 | Details |
4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one | C20H19FN4O2 | 763111-47-3 | Details |
1,3-DiMethyl 2-[4-(Methoxycarbonyl)-2-nitrophenyl]propanedioate | C13H13NO8 | 1160293-27-5 | Details |
Sorafenib impurity H | C21H16ClF3N4O3 | 1431697-81-2 | Details |
4-[4-[(Cyclopropylamino)carbonyl]aminophenoxy]-7-methoxy-6-quinolinecarboxamide | C21H20N4O4 | 417714-14-8 | Details |
1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-benzoyl]piperazine | C24H24N4O3 | 763113-06-0 | Details |
4-[1-(4-cyano-3-trifluoromethyl-phenylcarbamoyl)-1-methyl-ethylamino]-2-fluoro-N- | C20H18F4N4O2 | 1289942-55-7 | Details |
Lenvatinib Impurity I | Details |
4-(4-amino-3-(4-amino-3-chlorophenoxy)phenoxy)-7-methoxyquinoline-6-carboxamide | C23H19ClN4O4 | 2250242-56-7 | Details |
Neratinib dimethylamine N-oxide (M7) | C30H29ClN6O4 | 1376615-55-2 | Details |
1,3-Diethyl ester 2-[3-[(3aS,4S,6aR)-hexahydro-2-oxo-1,3-bis(phenylmethyl)-1H-thieno[3,4-d]imidazol-4-yl]propyl] Propanedioic acid | C29H36N2O5S | 101469-35-6 | Details |
Benzoic acid, 5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluoro-, methyl ester | C17H13FN2O3 | 1983186-05-5 | Details |
(R)-4-({2-[5-(2-Fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-hydroxy-amino)-butyric acid | Details |
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide | C14H20N4O3 | 1139453-98-7 | Details |
Regorafenib impurity R | C15H14FN3O3 | 2141961-84-2 | Details |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | C17H13NO4 | 2093243-16-2 | Details |
1-methyl-7-phenoxyisoquinolin-4-ol | Details |
(R)-4-((3-Carboxy-propyl)-{2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethyl}-amino)-butyric acid | Details |
Nintedanib impurity A | C30H31N5O4 | 894783-71-2 | Details |
Nilotinib Impurity 7 | C27H20F3N7O | 2119583-26-3 | Details |
Regorafenib Impurity P | C20H12ClF4N3O4 | 1187945-05-6 | Details |
4-[3-chloro-4-(propylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide | C21H21ClN4O4 | 417719-47-2 | Details |
Olaparib Impurity E | C36H28F2N6O4 | 2250242-62-5 | Details |
Ribociclib Impurity A | C22H28N8O | 1211441-59-6 | Details |
ethyl [3aS-(3aalpha,4beta,6aalpha)]-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valerate | C12H20N2O3S | 87573-52-2 | Details |
Ribociclib Impurity B | Details |
N-(4-((3-Chloro-4-(pyridin-2-ylMethoxy)phenyl)aMino)-3-cyano-7-ethoxyquinolin-6-yl)acetaMide | C26H22ClN5O3 | 915941-95-6 | Details |
Cabazitaxel N-1 | C53H63NO15 | 1354900-66-5 | Details |
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide | C21H15ClF4N4O4 | 835621-11-9 | Details |
4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide | C17H14ClN3O3 | 417722-93-1 | Details |
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate | C24H18ClN3O5 | 417722-95-3 | Details |
(Z)-1-(2-((4-(((6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)-4-methylpiperazine 1-oxide | Details |
(1a-methyl-6-oxo-3-phenoxy-1,1a,6,6a-tetrahydroindeno[1,2-b]azirine-6a-carbonyl)glycine | C19H16N2O5 | 2301113-15-3 | Details |
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)thioureido)-2-fluoro-N-methylbenzamide | C17H12F4N4OS | 1798807-39-2 | Details |
(R)-4-{2-[5-(2-Fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino}-butyric acid ethyl ester | Details |
Ribociclib Impurity T | Details |
Capecitabine-2',3'-cyclic Carbonate | C16H20FN3O7 | 921769-65-5 | Details |
7,10-Dimethoxy-10-DAB III | C31H40O10 | 183133-94-0 | Details |
OseltaMivir IMpurity A | C14H24N2O4 | 1364932-19-3 | Details |
Lenvatinib Impurity K | C22H20ClN3O5 | 417717-20-5 | Details |
Enzalutamide carboxylic acid | C20H13F4N3O3S | 1242137-15-0 | Details |
4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-ethoxy-6-[(1-methyl-2-pyrrolidinylidene)amino]-3-quinolinecarbonitrile | C29H27ClN6O2 | 1144516-21-1 | Details |
Lenvatinib N-Descyclopropyl Impurity | C18H15ClN4O4 | 417719-51-8 | Details |
6-Quinolinecarboxamide, 4-hydroxy-7-methoxy- | C11H10N2O3 | 2110414-05-4 | Details |
1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4R,6aR)- | C10H16N2O3S | 4375-00-2 | Details |
1-((dimethylamino)methyl)-7-phenoxyisoquinolin-4-ol | C16H13NO2 | 2756726-89-1 | Details |
(R)-5-(2-Fluoro-3-methoxy-phenyl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-3-[2-(2-oxo-pyrrolidin-1-yl)-2-phenyl-ethyl]-1H-pyrimidine-2,4-dione | Details |
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE | C13H12FN3O2 | 757251-39-1 | Details |
5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | C15H22FN3O6 | 910129-15-6 | Details |
cis-(-)-1,3-Dibenzylhexahydro-2-oxo-1H-thieno[3,4-d]iMidazole-4-valeric Acid | C24H28N2O3S | 33607-60-2 | Details |
Sorafenib Related Compound B | C14H13N3O3 | 2004659-84-9 | Details |
N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]formamide | C25H20ClN5O3 | 1144516-20-0 | Details |
Lenvatinib Impurity O | C20H19ClN4O4 | 2143930-76-9 | Details |
N,N''-Bis[3-(trifluoromethyl-4-cyanophenyl]urea | C17H8F6N4O | 1895865-11-8 | Details |
sodium (R)-4-{2-[3-(2-Fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino}-butyrate | Details |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester | C18H16N4O2 | 917392-54-2 | Details |
6-amino-4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-7-ethoxyquinoline-3-carbonitrile | C24H20ClN5O2 | 848139-78-6 | Details |
tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate | C25H27FN4O4 | 763114-04-1 | Details |
Neratinib Impurity E | Details |
(Z)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-7-carboxylate | C56H54N8O7 | 2097505-01-4 | Details |
ethyl 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate | C19H17NO4 | 1809286-36-9 | Details |
Regorafenib Impurity C | Details |
4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide | C20H18FN5O3 | 1855006-12-0 | Details |
(3S, 4S, 5R) - 5-acetylamino-4-amino-3 - (pentane-3-oxy) cyclohexene-1-ethyl formate | C16H28N2O4 | 1035895-88-5 | Details |
OSELTAMIVIR ACID | C14H24N2O4 | 187227-45-8 | Details |
1H-Thieno[3,4-d]imidazole-4-valeric acid, hexahydro-2-oxo-, stereoisomer (8CI) | C10H16N2O3S | 21788-37-4 | Details |
(R)-3-(2-Amino-2-phenyl-ethyl)-5-(2-fluoro-3-methoxy-phenyl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione; with sulfuric acid | Details |
Ribociclib Impurity U | Details |
1'N-Benzyl Biotin | C17H22N2O3S | 76335-62-1 | Details |
OseltaMivir Acid Methyl Ester | C15H26N2O4 | 208720-71-2 | Details |
OseltaMivir IMpurity D | C11H13NO4 | 1346604-18-9 | Details |
4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide | C28H22F3N7O | 641571-15-5 | Details |
Lenvatinib Impurity M | C21H18ClN3O5 | 417717-21-6 | Details |
Olapali impurity D | C24H25FN4O3 | 2250243-17-3 | Details |
(3aS,4S,5RS,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic Acid 5-Oxide | C10H16N2O4S | 23015-53-4 | Details |
Levatinib cyanide impurity | C21H17ClN4O3 | 1882873-21-3 | Details |
Nilotinib Ethylimidazole Analog | C29H24F3N7O | 2119583-24-1 | Details |
4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate | Details |
4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylic acid | Details |
5-(2-Fluoro-3-methoxy-phenyl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-3-(2-hydroxyimino-2-phenyl-ethyl)-6-methyl-1H-pyrimidine-2,4-dione | Details |
Ribociclib Impurity D | Details |
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine | C15H22FN3O6 | 162204-30-0 | Details |
4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxy-6-(2-hydroxy-5-oxopyrrolidin-1-yl)quinoline-3-carbonitrile | C28H24ClN5O4 | 1144516-15-3 | Details |
Cabazitaxel Impurity A | Details |
FLUCOFURON | C15H8Cl2F6N2O | 370-50-3 | Details |
(1S,2S,6R)-3,5-dibenzyl-4-oxo-8lambda4-thia-3,5-diazatricyclo[6.3.0.0^{2,6}]undecan-8-ylium bromide | C22H25BrN2OS | 33719-11-8 | Details |
4-ethoxy-7-methoxyquinoline-6-carboxamide | C13H14N2O3 | 2143930-77-0 | Details |
(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)glycylglycine | C17H14N2O3 | 2243809-28-9 | Details |
Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]- | C28H21ClF3N7O | 2469039-94-7 | Details |
sodium (S)-4-{2-[5-(2-Fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino}-butyrate | Details |
Ribociclib Impurity C | Details |
4-N-Desacetyl-5-N-acetyl OseltaMivir | C16H28N2O4 | 956267-10-0 | Details |
4-[6-[[7-cyclopentyl-6-[(diMethylaMino)carbonyl]-7H-pyrrolo[2,3-d]pyriMidin-2-yl]aMino]-3-pyridinyl]- | C28H38N8O3 | 1374639-78-7 | Details |
N-(4-chloro-3-(trifluoromethyl)phenyl)- | C9H7ClF3NO | 348-90-3 | Details |
Oxo Enzalutamide | C21H16F4N4O3 | 1242137-18-3 | Details |
4-(4-aminophenoxy)-7-methoxyquinoline-6-carboxamide | C17H15N3O3 | 417722-79-3 | Details |
O-methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamothioate | C10H7F3N2OS | 1895865-10-7 | Details |
1-((dimethylamino)methyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylic acid | Details |
Product Total: Product Page: | ||||
1 2 3 4 |